Novo Anticipates Q4 Soft Launch For Closely Watched Oral GLP-1 Agent Rybelsus In The US

 
• By Mandy Jackson
  
Form close up, fountain pen and approved stamped on a document. Soft focus. - Image
The US FDA approved Rybelsus, the first oral GLP-1 agonist. • Source: Shutterstock

More from New Products

More from Scrip